Acquired Immunodeficiency Syndrome
Find comprehensive information on Acquired Immunodeficiency Syndrome (AIDS) diagnosis, including clinical documentation, medical coding, and healthcare guidelines. Learn about HIV disease progression, AIDS-defining illnesses, and relevant ICD-10 codes for accurate medical record keeping and billing. This resource provides essential information for healthcare professionals, coders, and patients seeking to understand AIDS diagnosis and management.
Late stage HIV infection marked by severely weakened immunity, increasing risk of opportunistic infections and cancers.
Frequent infections, rapid weight loss, persistent fever, swollen lymph nodes, fatigue, diarrhea.
HIV clinics, infectious disease departments, primary care facilities, community health centers.
ICD-10 Code Families
Complete code families applicable to B20
When to use each related code
| Description | When to use |
|---|---|
| Late-stage HIV infection with severe immune deficiency. | Use for patients meeting CDC criteria for AIDS (CD4 count <200 or presence of AIDS-defining illness). |
| Infection with Human Immunodeficiency Virus. | Use for all stages of HIV infection, including asymptomatic and early stages. Use in conjunction with staging codes. |
| HIV infection not progressing to AIDS. | Use for HIV-positive individuals who have not developed AIDS-defining conditions and maintain sufficient CD4 counts. |
Best-practice checklist
- ✓Document HIV viral load and CD4 count.
- ✓Specify opportunistic infections (e.g., PCP, KS).
- ✓Detail AIDS-defining illnesses if present.
- ✓Note current antiretroviral therapy (ART) regimen.
- ✓Record history of HIV diagnosis and progression.
Common pitfalls to avoid
Coding AIDS without specifying stage (e.g., asymptomatic, symptomatic, progression to AIDS) leads to inaccurate severity reflection and reimbursement.
Miscoding HIV infection as AIDS or vice versa, impacting data integrity for public health reporting and resource allocation.
Failure to capture all AIDS-defining opportunistic infections or coding them incorrectly can affect quality metrics and reimbursement.
Best-practice tips
- 01HIV screening, early ART initiation for AIDS prevention. ICD-10: B20
- 02Monitor CD4 count, viral load for disease progression. SNOMED CT: 14028007
- 03Opportunistic infection prophylaxis, ART adherence counseling. HCC: RAF
- 04Promote safe sex practices, harm reduction strategies. ICD-10: Z72.51
- 05Address psychosocial needs, mental health support. CPT: 90837
Step-by-step checklist
- 1
Confirm HIV infection diagnosis (ICD-10: B20)
- 2
CD4 count <200 cells/mm3 or AIDS-defining illness present
- 3
Document opportunistic infections (e.g., PCP, KS)
- 4
Review patient history for relevant risk factors
- 5
Assess and document current medications and treatments
Ready-to-paste narrative
Patient presents with signs and symptoms suggestive of Acquired Immunodeficiency Syndrome (AIDS), a late stage of HIV infection. The patient reports experiencing opportunistic infections, including recent episodes of Pneumocystis pneumonia (PCP) and oral candidiasis (thrush). Weight loss, fatigue, and lymphadenopathy are also noted. Laboratory findings reveal a significantly depleted CD4 T-cell count (below 200 cells/mm3) confirming the diagnosis of AIDS. HIV viral load is elevated. The patient's medical history includes a prior diagnosis of Human Immunodeficiency Virus (HIV) infection, though adherence to antiretroviral therapy (ART) is reportedly inconsistent. Differential diagnoses considered included other immunodeficiency disorders, but the clinical picture and laboratory results are consistent with AIDS. The patient's current presentation necessitates initiation of highly active antiretroviral therapy (HAART) to manage HIV viral load and improve immune function. Patient education regarding medication adherence, opportunistic infection prophylaxis, and lifestyle modifications to support immune health will be provided. Referral to infectious disease specialist and social services for support and resources will be made. Prognosis is dependent on response to HAART and management of opportunistic infections. Follow-up appointments are scheduled to monitor CD4 count, viral load, and overall clinical status. ICD-10 code B20 will be used for billing and coding purposes. This documentation supports medical necessity for ongoing HIV care and treatment.
Common questions and answers
What are the latest CDC recommendations for HIV pre-exposure prophylaxis (PrEP) initiation and management in adolescents and young adults?+
The CDC recommends offering PrEP to all adolescents and young adults who report behaviors that increase their risk of HIV acquisition, such as inconsistent condom use with partners of unknown HIV status or injection drug use. Clinicians should assess risk individually and discuss PrEP as a viable prevention strategy. Recent updates emphasize shared decision-making with patients, tailoring the PrEP regimen (daily oral or on-demand), and ensuring adherence support. Explore how the CDC's clinical practice guidelines provide detailed guidance on PrEP eligibility, prescription, monitoring, and follow-up care, including specific recommendations for adolescent and young adult populations.
How can clinicians differentiate between acute HIV infection and other common viral illnesses presenting with similar symptoms like fever, rash, and lymphadenopathy?+
Acute HIV infection can mimic many common viral illnesses, making diagnosis challenging based solely on clinical presentation. While symptoms like fever, rash, and lymphadenopathy are common, they are not specific to HIV. A thorough sexual history and risk assessment are crucial. Clinicians should consider a fourth-generation HIV antibody/antigen combination test for early detection. If negative but clinical suspicion remains high, repeat testing in 2-4 weeks or HIV RNA testing should be performed. Consider implementing a standardized protocol in your practice to improve early HIV diagnosis and prompt initiation of antiretroviral therapy (ART), which is essential for optimal patient outcomes. Learn more about the CDC's diagnostic testing algorithm for HIV infection.
What are the current best practices for managing HIV-related neurological complications in patients with long-term viral suppression on antiretroviral therapy (ART)?+
Even with effective ART achieving viral suppression, some individuals living with HIV may experience neurological complications like HIV-associated neurocognitive disorders (HAND). Regular neurological assessments are crucial. Management includes optimizing ART regimens, addressing comorbidities like cardiovascular disease and substance use, and providing symptomatic management of cognitive impairment. Explore how emerging research is investigating adjunctive therapies to improve neurological outcomes in these patients. Consider implementing cognitive screening tools in your practice for early detection and appropriate referrals to neurology specialists.
Clinical accuracy: This information is provided for documentation and coding guidance and should not replace professional medical judgment.
Coding standard: ICD-10-CM, current FY guidelines.